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Aspirin and cognitive function
Benefit has not yet been shown but may be due to difficulties in selecting the 
right outcome measure
Growing old is associated with a greater risk of falls, 
reduced bone volume, vascular events, cognitive decline, 
and depression. Although it is relatively straightforward 
to study the effects of interventions on the physical 
risks associated with ageing, studying effects on cog-
nitive function is more difficult. Age related cognitive 
impairment affects about 5% of people over 65 in the 
developed world, and about half of those affected have 
memory loss.1 In this week’s BMJ, Kang and colleagues 
assess the impact of aspirin on cognitive function in a 
subgroup of elderly women enrolled in the women’s 
health study2—a randomised controlled trial of the effect 
of aspirin on cardiovascular morbidity and cancer.
What is the evidence on interventions for delaying 
or preventing age related cognitive decline? Drugs for 
dementia produce transient symptomatic improvements 
by enhancing cholinergic neurotransmission but they 
do not delay progress to severe dementia. Molecular 
neurobiological and epidemiological studies suggest 
several interventions (such the possible neuroprotec-
tive effects of non-steroidal anti-inflammatory drugs3) 
that may slow cognitive decline and postpone the onset 
of dementia. Many of these population based studies 
identify risk factors for vascular disease as targets for 
preventing dementia. These studies also highlight the 
fact that complex research designs are necessary to take 
account of confounding by the differential effects of sur-
vival and the contribution of lifelong habits associated 
with retention of good health. Persisting uncertainty 
about the timing and nature of the prodromal phase of 
dementia remains an important obstacle to assessing the 
efficacy of interventions. Including participants in trials 
who are not at increased risk of cognitive decline will 
reduce the likelihood of detecting efficacy.
So far, results have been encouraging. Treatment 
of hypertension is beneficial in older people, with 
well established cognitive benefits, possibly including 
reduced risk of transition to dementia.4 Evidence is 
strengthening in support of folic acid supplementation to 
reduce hyperhomocysteinaemia (a putative vascular risk 
factor), which in turn improves cognition,5 although it is 
unclear whether supplementation will prevent dementia. 
The case for antioxidant vitamin supplements remains 
weak, because although some reduction in the incidence 
of dementia seems plausible, good quality trials are lack-
ing. Likewise, marine oil supplementation has not been 
adequately tested.6
A case therefore exists for reducing vascular risk 
factors to maintain cognitive function. The preventive 
role of different drug groups with contrasting actions on 
the cascades of molecular events that lead to vascular 
disease also needs to be investigated. Aspirin has a 30 
year track record as a candidate for overall reduction of 
cardiovascular risk. The women’s health study offered 
a golden opportunity to examine its potential to delay 
cognitive decline.
The study by Kang and colleagues1 found no sig-
nificant difference in cognitive function at any of the 
three assessments (the first one on average 5.6 years 
after randomisation) administered every two years. The 
mean difference in decline in the global score from the 
first to the final cognitive assessment was 0.01 (95% 
confidence interval −0.02 to 0.04). The study recruited 
healthy women over 45 and achieved high follow-up 
rates. Efforts were made to control for confounders 
(smoking, alcohol, exercise, body mass index, blood 
pressure, diabetes, and incident depressive and vascular 
disease). High completion rates of repeated cognitive 
assessment using telephone administered tests with pre-
specified “real world” outcome measures in a large well 
powered study allow conclusions to be drawn about the 
lack of effect of aspirin on cognition in this population.
Limitations—including sampling bias towards inclu-
sion of white American women with low morbidity—
preclude generalising the results to other populations 
at higher risk, and of course to men. Doctors who pre-
scribe aspirin will be aware of the gastrointestinal com-
plications identified in this study.
In addition, cognitive function was assessed by tele- 
phone interview, and was therefore entirely verbal and 
dependent on memory. This may seem reasonable 
when memory impairment is a core concept in research 
into dementia. However, there is a contrary view that 
the prodrome of Alzheimer’s disease (the most com-
mon form of dementia) extends beyond memory loss 
to include deficits in executive functions, mental speed,7 
and attention,8 and that visuospatial learning may also 
be important. These reports, with others, lead to the 
proposition that the early signs of dementia arise not 
from selective damage to key anatomical (“bottleneck”) 
structures crucial for verbal memory, but from pathol-
ogy that breaks connections between brain structures 
serving several cognitive domains.9 In these terms, 
impairment of verbal memory alone is not the best early 
indicator of the dementia prodrome—deficits in atten-
tion and executive function are better predictors. Some 
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support for this “disconnection hypothesis” is derived 
from the study’s finding of impairments on “category flu-
ency,” a seemingly explicit task of memory requiring the 
naming of as many animals as possible in one minute. 
While interpretation of this test is complex—involving 
effortful retrieval, loss of knowledge, and both directed 
and sustained attention10—its potential importance as a 
marker of frontal or executive integrity should not be 
overlooked if premature conclusions on aspirin are to 
be avoided.
Better quality research into cognitive decline in later 
life is needed, but many pitfalls blight the road to suc-
cess. Ultimately, once multiple risk factors are identi-
fied, common pathways to the onset and prevention of 
Alzheimer’s disease will be charted.11 As this is achieved, 
measurements and study designs will need to move away 
from categorical approaches, and assess the confound-
ing effects of ill health in old age and to place people in 
their correct social context in terms of dependency and 
lifelong cognitive abilities. The US health and retirement 
study design is informative about many of these issues.12 
Ongoing developments into the sources of individual dif-
ferences in cognitive ageing acting across the life course13 
will provide some solutions to these taxing methodologi-
cal problems.
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Some bereaved people develop severe long term reac-
tions to their loss. This kind of reaction may be asso-
ciated with adverse health outcomes and has recently 
been termed “complicated grief.”1 The syndrome is 
more common after unexpected and violent deaths such 
as suicide.2 3 People bereaved by suicide are also more 
likely than those bereaved by other deaths to experience 
stigmatisation, shame, guilt, and a sense of rejection.4 
People going through normal or uncomplicated grief 
reactions after a death usually do not need or benefit 
from specific interventions other than support—indeed 
these may be contraindicated.5 The potentially severe 
implications for people who develop complicated grief 
suggest, however, that special treatment may be indi-
cated. But are these interventions effective?
The randomised controlled trial reported by de Groot 
and colleagues in this week’s BMJ is one of few evalu-
ations in this field.6 The findings indicate that provi-
sion of a cognitive behaviour counselling programme 
of four sessions to relatives and spouses bereaved by 
suicide between three and six months after the death 
may have some benefits compared with usual care. 
Thus, while treatment groups did not differ at 13 months 
after the death in prevalence of complicated grief, the 
programme seemed to help prevent maladaptive grief 
reactions and perceptions of blame for the death.
This study highlights the question of how compli-
cated grief differs from normal grief, and other possible 
bereavement outcomes, and how clinicians—especially 
in primary care—should best manage people at risk. 
A syndrome of complicated grief has been proposed 
for inclusion in the fifth version of the Diagnostic and 
Statistical Manual of Mental Disorders of the American 
Psychiatric Association.1 In contrast to uncomplicated 
grief, people with complicated grief seem to be in a 
state of chronic mourning. The proposed criteria require 
that the bereaved person has persistent and disruptive 
yearning, pining, and longing for the deceased. The 
criteria include four out of eight symptoms that must 
be experienced frequently or to a severely distressing 
and disruptive degree (or both). The eight symptoms 
are trouble accepting the death, inability to trust others 
since the death, excessive bitterness related to the death, 
uneasiness about moving on with life, detachment from 
other people to whom the person was previously close, 
the feeling that life is now meaningless, the view that 
the future holds no prospect for fulfilment, and agita-
tion since the death. Importantly, to fulfil the diagno-
sis these symptoms must have persisted for at least six 
months. They must also have resulted in considerable 
ReseARch, p 994 
Keith hawton  
professor of psychiatry  
University of Oxford, Department 
of Psychiatry, Warneford Hospital, 
Oxford OX3 7JX 
keith.hawton@psych.ox.ac.uk
Competing interests: None declared. 
Provenance and peer review: 
Commissioned; not externally peer 
reviewed.
BMJ 2007;334:962-3 
doi:10.1136/bmj.39206.507488.BE
complicated grief after bereavement
Psychological interventions may be effective
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impairment in social, occupational, and other major 
areas of functioning.1 Complicated grief may be associ-
ated with increased risk of cancer, hypertension, car-
diac events, and suicidal ideation,1 plus adverse health 
behaviours such as increased smoking and alcohol 
misuse.7 Although complicated grief is associated with 
an increased risk of depressive disorders, it is clearly 
distinguished from depression.8
Detection of people at risk is important. Sudden 
unexpected deaths appear to be associated with greater 
risk. Risk is also increased if the relationship with the 
deceased person was a dependent one. Other factors 
include early family experiences that may have under-
mined the person’s sense of security—such as abuse 
and neglect or separation anxiety—and lack of a sup-
portive network.1 Practitioners may therefore be able 
to identify some people at risk. However, given the 
usual limitations of using risk factors for determining 
prognosis, monitoring the bereaved through occasional 
brief contact will also be important, especially as people 
who develop complicated grief may be reluctant to seek 
help from clinicians.1 This will also provide opportunity 
for giving support. For people bereaved by suicide, self 
help can be encouraged through recommended read-
ing material.9
But what can be done to help people at risk, or those 
identified with a complicated grief reaction? The results 
of the trial by de Groot and colleagues indicate that 
specific interventions at an early stage may be helpful 
for people at risk who have experienced a sudden loss. 
The brevity of the intervention (four sessions) makes 
it attractive, although replication and improved results 
of such an intervention would increase confidence in 
recommending it. Once complicated grief has been 
identified, a more intensive approach designed to treat 
the condition seems to be effective, especially for people 
who have experienced a sudden violent loss.10 Provi-
sion of cognitive behaviour therapy through an interac-
tive internet based programme has also had impressive 
results.11 Development of more resources to manage 
complicated grief is clearly required, together with fur-
ther evaluations. However, current evidence indicates 
that not only is complicated grief a serious adverse out-
come of bereavement, but that it may be dealt with 
effectively through carefully designed interventions.
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Socioeconomic differences in health have been 
described since the 16th and 17th centuries,1 2 but only 
recently has reducing them been central to public health 
policy in many Western countries.3 Over the past three 
decades, epidemiological studies have confirmed the 
existence of socioeconomic inequalities in a range of 
health outcomes, including premature mortality, car-
diovascular disease, obesity, diabetes, self reported ill 
health, and smoking related cancers, and have explored 
potential mechanisms linking lower socioeconomic posi-
tion to poorer health.4 The Whitehall cohort studies 
have made important contributions to this literature.5
Several studies,6-9 including a publication from White-
hall II,10 have found that poorer socioeconomic position 
is associated with worse morbidity, mortality, and self 
reported health in older people. In this week’s BMJ, a 
new analysis of data from Whitehall II by Chandola 
and colleagues examines the extent to which socioeco-
nomic inequalities in self reported physical and mental 
health continue into older age.11 The paper adds to the 
literature by using repeated measures of socioeconomic 
position and self reported health, both of which may 
change with age. The paper demonstrates one of the 
strengths of prospective cohort studies—the ability to 
examine changing relations between health related 
characteristics over time.
Three key messages emerge: firstly, self reported 
physical health declines with age in all groups (women 
and men, people who are retired and those who con-
tinue work, and people in all employment grades); sec-
ondly, in contrast, self reported mental health increases 
in all groups; and thirdly the rate of decline in physical 
health with age is greater in those from lower employ-
ment grades than those from higher employment grades, 
which results in a widening of health inequalities with 
age.11
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The authors focus specifically on socioeconomic in- 
equalities. But their repeated measurements and 
detailed analyses allow other inequalities to be 
explored. Figure 2 in their paper shows the trajectories 
of health change with age by occupational grade for the 
final phase (2002-4) of the study. However, the authors 
do not highlight that the interactions of age with time 
period included in their statistical model suggest that 
these trajectories changed over time. We calculated the 
trajectories of physical and mental health for each time 
period that the study covered using data from the full 
results of model I, presented in the appendix to the 
paper (figs 1 and 2).11 We found that in the first period 
(1991-3) physical health did not decline with increasing 
age, and during the rest of the 1990s the decline in self 
reported physical health with age was much less pro-
nounced than that seen since 2000 (fig 1). With respect 
to self reported mental health, in the early 1990s the 
increase with age was more noticeably linear—continu-
ing to increase into later older age—than in more recent 
years, where at older age the improvement in mental 
health flattens off (fig 2). The differing impressions given 
by trajectories in the different periods are a reminder 
of how difficult it can be to summarise the results of 
complex statistical models in a transparent way.
These findings suggest that people in recent years 
perceive a greater decline in their physical health and 
a smaller improvement in their mental health as they 
age than people did a decade ago. Reasons underlying 
this cannot be determined from the data presented, but 
continued reporting in the media of the “burden” of an 
older population, together with changing roles of the 
family and society, and changing attitudes in society 
towards care for older people might be important.
The results of the statistical model also show that 
sex is the strongest predictor of physical health; the 
physical scores of the women in the reference group 
were, on average, 2.65 points lower than those for the 
men in that group. This compares to a difference of 
1.60 points between the lowest and highest employ-
ment grades in this group. Women also reported worse 
mental health (difference of 1.96 points on the mental 
health score). As the authors report no evidence of 
statistical interaction between sex and age, the results 
suggest that the sex differences found in the reference 
age persist as people get older.
In summary, the full model results suggest that socio- 
economic inequalities in self reported health persist 
and possibly widen with age, that the relation between 
age and self reported health changes over time, and 
that women have worse self reported health than men 
at all ages and time points.
The implications of the findings for public health 
are uncertain because the meaning of differences of 
this size in self reported physical or mental health 
is unclear. A difference of 1 in the short form 36 
(SF-36) score probably corresponds to 0.05-0.07 of 
a standard deviation: in previous UK based studies 
the standard deviation has ranged from 15-20, with 
similar means to those published in table 1 of the 
paper11 Quantifying similar trajectories for objective 
health outcomes (such as blood pressure, fasting and 
postload glucose, lipid values, incident diabetes, and 
cardiovascular disease) that have a clearer meaning to 
clinicians, public health practitioners, and the public, 
and exploring how these change with socioeconomic 
position, age, and sex over different time periods, is 
something that Whitehall II can do and that we look 
forward to seeing.
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In the worst case scenario, a pandemic of influenza 
in the United Kingdom would cause 750 000 excess 
deaths. In the short term, gross domestic product 
could fall by some 0.75%, and in the longer term the 
cost to the nation could be around £170bn (€250bn; 
$350bn). 
On 16 March 2007, the Department of Health and 
the Cabinet Office jointly published a new draft plan 
for pandemic flu.1 The plan builds on and replaces 
the October 2005 plan.2 It is supported by a range of 
additional documents related to acute hospitals, health 
care in the community,3 an “operational and strategic 
framework” for adults in social care,3 guidelines for 
staff in social care settings,3 ambulance services,3 and 
an ethical framework.3 Some documents offer strategic 
guidance, some offer operational guidance, and others 
guidance for individuals. Comments are requested on 
all draft documents by 16 May 2007.
The purpose of the framework is to set out the gov-
ernment’s strategic approach to limit the domestic 
spread of a pandemic and minimise harms to health, 
the economy, and society. The document proposes a 
national framework within which organisations respon-
sible for planning, delivering, or supporting local 
responses should develop and maintain integrated 
operational arrangements. The framework has many 
strengths.
Firstly, it makes explicit assumptions that guide the 
strategy—for example, in relation to clinical attack rates 
and estimates of excess deaths that might follow. In 
addition, explicit policy assumptions are delineated for 
planning purposes. These deal with important themes 
such as transport policy (for example, travel restric-
tions, health screening, financial support to airlines), 
international policy (such as repatriation issues, medi-
cal assistance to British nationals overseas), essential 
services, education and social mixing, broadcasting, 
pharmaceutical interventions, communications, and 
response and coordination. These issues have previ-
ously been neglected by many national strategic plans.4 
Moreover, the policy assumptions are strategically 
linked to World Health Organization pandemic flu 
phases. The assumptions concur with WHO advice, 
again an area neglected in many national strategic 
plans and something likely to result in problems for 
international coordination and cooperation.4 5
In their February 2007 report on the status of 
European Union preparedness for pandemic flu, the 
European Centre for Disease Prevention and Control 
(ECDC) highlighted several neglected areas.6 One 
of these was making plans operational at local level, 
which is a profound challenge for all countries. The 
range of documents in this consultation exercise sug-
gests this remains a testing exercise for the Department 
of Health.
In the UK, as the new plan makes clear, the pri-
mary responsibility for planning and responding to any 
major emergency rests with local organisations, acting 
individually and collectively through local “resilience 
forums.” Thus, operational planning will be guided by 
central government but will need to be implemented 
locally. However, can timely and effective implementa-
tion in a time of crisis be achieved under a devolved 
system? If it can, then preplanning is crucial—and these 
documents highlight the amount of planning needed 
at the local level.
The UK’s operational plans remain under develop-
ment. A checklist for how the arms of the health system 
relate to health care in a community setting offers a 
useful way forward. However, this tells organisations 
only what needs to be done—not how to do it—and 
similar checklists are not available for all stakeholder 
organisations. Moreover, no structured mechanism 
exists through which organisations can draw from the 
lessons of others or ensure their operational plans are 
similar to others. Monitoring implementation of local 
operational plans will be important to avoid chaos in 
a crisis.
Some resources—such as strain specific vaccine, anti-
virals, and antibiotics—may be in short supply. It is 
unclear who will receive them, how and where priority 
decisions will be made, and whether responses across 
local areas will be consistent. While the framework 
outlines a variety of options, the document offers little 
guidance for local planners. The linked ethical frame-
work document largely avoids the issue of prioritisa-
tion; it takes a medical (rather than a public health) 
approach and mostly neglects the strategic aims.
It could be that some people may be deemed more 
worthy of receiving treatment or prevention resources 
because of their impact on transmission dynamics, pub-
lic health, the economy, or on mitigating “social harm.” 
But this issue is not dealt with. Some countries’ plans 
offer more explicit guidance on the controversial issue 
of how to allocate scarce resources.5 This is not simply 
an abstract moral dilemma. Further guidance from the 
Department of Health is promised.
Severe acute respiratory syndrome, a dry run for 
pandemic flu, taught us that “there should be clarity 
established beforehand, as to what decisions are taken 
at what level and by whom during an epidemic.”7 In 
acute crises, devolved authority tests health systems 
differently from top-down systems.8 Indeed, the gov-
ernment’s generic guidance, “emergency response and 
recovery,” referred to in the framework, outlines eight 
guiding principles. Among these is preparedness, “all 
organisations and individuals that might have a role to 
play in emergency response and recovery should be 
properly prepared and be clear about their roles and 
responsibilities.”9 Concern persists at local level that 
current plans for pandemic flu in the UK do not take 
account of what we have learnt from the experience 
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with severe acute respiratory syndrome.10
Ultimately, it will be a remarkable achievement if 
devolved operational authority is successful. History 
suggests that the political imperative in a national 
(indeed global) crisis will be to centralise strategic and 
operational authority. If this happens then much of 
the planning could be redundant and an alternative 
approach might be needed.
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On 1 July 2007 smoking will be banned from most 
enclosed public places and workplaces in England, 
with fines for people who break the law.1 The govern-
ment of the United Kingdom estimates that this will 
result in a fall of 1.7 percentage points in the preva-
lence of smoking in England and an estimated annual 
saving of £100m (€147m; $200m) to the National 
Health Service.2
National legislation inevitably puts pressure on local 
health services to deliver its promises. Yet timely and 
reliable information to help implement and monitor 
public health policies like smoking cessation is not 
always easy to find. Public health information exists 
in many forms in disparate locations. The UK govern-
ment recognises the lack of a comprehensive collec-
tion of information for public health, and attempts are 
being made to rectify this.3
Data, evidence, and narrative information form 
the three main types of public health information. 
Data—which is quantitative—usually describes a health 
service by its inputs (such as financial), outputs (such 
as hospital activity), and outcomes (such as survival 
rates). When displayed as trends over time or compari-
sons between places such data can be powerful. Sec-
ondly we have evidence, which comes from published 
research. Finally, we have narrative—qualitative infor-
mation based on the experience and insights of people 
who use and provide a health service—the equivalent 
of a patient’s history as recorded by a doctor.
Information on public health is less readily acces-
sible than that available to colleagues working in more 
clinical settings, and it is time consuming to find. Prac-
tising public health practitioners also need tools and 
worked examples that can be applied to their local 
situation.
A new online service from the BMJ Publishing 
Group, BMJ Health Intelligence, aims to fill this gap. 
It takes essential public health topics and “unpacks” 
them, putting data, evidence, and examples of good 
practice into context in a way that is easy to find and 
apply. This same easy approach is being developed by 
BMJ Health Intelligence to support commissioning, 
especially for general practitioners (GPs) who have 
little experience in this area.
As gatekeepers to secondary care and with a com-
mitment to a defined practice population, GPs can 
exert considerable influence over hospital referrals 
and activity in secondary health care. They also have 
access to accurate information about the numbers and 
types of referrals from their computerised information 
systems and have considerable knowledge about the 
health of the local population.
The Department of Health in England has rec-
ognised GPs’ vantage point and given them a lead 
role in practice based commissioning. This makes it 
even more important for GPs to see their acutely ill 
patients within the wider context of the whole popula-
tion. Despite this obligation to get involved in commis-
sioning, many GPs have little time to consider these 
wider health issues. To overcome this, interested GP 
should be encouraged to acquire public health skills 
and work alongside their public health colleagues.4 
BMJ Health Intelligence is also developing support 
for GP commissioners with easy access to evidence, 
data, tools, and examples of good practice. This will 
help establish the necessary long term relationships 
between primary and secondary health care and shape 
local patient pathways within a finite budget.5
In clinical medicine, an intervention cannot be pro-
moted without some evidence of effectiveness. In public 
health, where funding is even more limited than in other 
specialties, it is even more imperative that interventions 
are both cost effective and clinically effective. Evidence 
is not always available, but where it does exist the serv-
ice offered by BMJ Health Intelligence classifies it into 
what works, what may work, and what doesn’t work.
The service—which launches this month—has been 
built with contributions from practitioners, and it 
will continue to evolve with users’ feedback. When 
the smoking ban comes into force on 1 July 2007, 
those who provide services for smokers will be better 
prepared.
Bringing public health information together
A new online service should benefit public health practitioners and GPs 
involved in commissioning
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